Gilead To Shell $1.25B On GSK Patent Settlement For Biktarvy
It doesn’t come as a shock when we hear that GlaxoSmithKline and Gilead Sciences are fighting out in HIV domain for a long time,...
Bharat Biotech To Soon Foray Into Nasal Covid-19 Vaccine
Bharat Biotech has been granted permission by India’s drug controller to execute standalone phase 3 clinical trials on the intranasal vaccine for COVID-19. Besides...
Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Australia's Therapeutic Goods Administration (TGA) has...
Moderna Starts Variant Specific Vaccine Trials After Pfizer
Moderna, the US biotech firm, has announced that it has initiated clinical trials of a booster that is especially designed to fight out the...
Biotech Companies In China Look To Have A Global Footprint
The biotechnology industry in China is coming of age as a major licencing deal has been signed between RemeGen Co Ltd and Seagen Inc,...
Biosimilar Space Disruption Lead By Novartis And Pfizer
As per GlobalData’s Thematic Research ecosystem, pharmaceutical giants Novartis and Pfizer are the best-positioned companies to take advantage of future biosimilars in the pharma...
Moderna To introduce The Fusion Of COVID-19 And Flu Booster
According to Moderna’s CEO, Stephane Bancel, the company is aiming to bring to the market a combination of COVID-19 and influenza booster in the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...